PS
RAPT

Peter Svennilson’s RAPT Therapeutics RAPT Stock Holding History

Peter Svennilson’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$181M Sell
703,812
-143,332
-17% -$31.8M 14.79% 4
2020
Q2 		$197M Hold
847,144
– – 16.45% 3
2020
Q1 		$144M Hold
847,144
– – 18.25% 4
2019
Q4 		$187M Buy
+847,144
New +$156M 22.34% 3

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Peter Svennilson's RAPT Position: Q3 2020 in Review

Peter Svennilson reduced its RAPT Therapeutics (RAPT) stake by 17% in Q3 2020, selling an estimated $31.8M and leaving 703,812 shares worth $181M. The position accounts for 14.79% of the portfolio, ranked #4.

Peter Svennilson first reported a position in RAPT in Q4 2019 and has held it in 4 quarters since. The position peaked at $197M in Q2 2020. 67 funds tracked by Wall St. Rank hold RAPT as of Q3 2020.

  • Peter Svennilson held 703,812 shares of RAPT Therapeutics worth $181M as of Q3 2020.
  • Peter Svennilson sold 143,332 RAPT Therapeutics shares in Q3 2020, an estimated $31.8M.
  • RAPT Therapeutics made up 14.79% of Peter Svennilson's portfolio in Q3 2020, its #4 holding.
  • Peter Svennilson first reported a position in RAPT Therapeutics in Q4 2019 and has held it in 4 quarters since.
  • Peter Svennilson's RAPT Therapeutics position peaked at $197M in Q2 2020.
  • 67 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2020.

Based on Peter Svennilson's 13F filing for Q3 2020, filed 4 Nov 2020.